Search results
Results from the WOW.Com Content Network
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.
The maker of Botox Allergan will be bought by Abbvie in a cash and stock deal valued at about $63 billion. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Connor Browne, a portfolio ...
Shareholders are not very pleased with Allergan plc (NYSE:AGN) after it reported first-quarter results for 2018. Allergan stock is worth a second look. Allergan’s sale of Teva stock is ...
Stuck in a trading range, Allergan (NYSE: AGN) needs to win back investors as the company continues to look for new drug products to drive sales growth. Confidence is so bad that activist AGN ...
Under Papa's leadership, by early 2018, the company had become profitable again; had settled the Allergan case for less than expected; and had lowered its debt by $6.5 billion. [ 101 ] [ 102 ] The company had divested itself of 13 non-core businesses, reducing its debt to $25 billion, and had settled or dismissed 70 pending lawsuits, including ...
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
Stock name Symbol Country of origin A. O. Smith Corporation: AOS: US A10 Networks, Inc. ATEN: US AAC Holdings Inc. AAC: US AAR Corporation: AIR: US Aaron's Inc.
For premium support please call: 800-290-4726 more ways to reach us